173 related articles for article (PubMed ID: 21347689)
1. Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.
Yawata T; Maeda Y; Okiku M; Ishida E; Ikenaka K; Shimizu K
J Neurooncol; 2011 Sep; 104(2):497-507. PubMed ID: 21347689
[TBL] [Abstract][Full Text] [Related]
2. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
3. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of a mouse myelin basic protein promoter for gene therapy of malignant glioma: myelin basic protein promoter is strongly active in human malignant glioma cells.
Miyao Y; Shimizu K; Tamura M; Akita H; Ikeda K; Mabuchi E; Kishima H; Hayakawa T; Ikenaka K
Jpn J Cancer Res; 1997 Jul; 88(7):678-86. PubMed ID: 9310141
[TBL] [Abstract][Full Text] [Related]
6. High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.
Balani P; Boulaire J; Zhao Y; Zeng J; Lin J; Wang S
Mol Ther; 2009 Jun; 17(6):1003-11. PubMed ID: 19240692
[TBL] [Abstract][Full Text] [Related]
7. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
8. [Selective gene therapy of malignant gliomas using brain-specific promoters: its efficacy and basic investigations].
Shimizu K
Nihon Rinsho; 1994 Nov; 52(11):3053-8. PubMed ID: 7527868
[TBL] [Abstract][Full Text] [Related]
9. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
[TBL] [Abstract][Full Text] [Related]
10. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.
Tai CK; Wang WJ; Chen TC; Kasahara N
Mol Ther; 2005 Nov; 12(5):842-51. PubMed ID: 16257382
[TBL] [Abstract][Full Text] [Related]
11. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
13. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
[TBL] [Abstract][Full Text] [Related]
14. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
16. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models.
Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z
Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
19. Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter.
Pan J; Wang H; Liu X; Hu J; Song W; Luo J; Jiang S; Yan F; Zhai B
PLoS One; 2015; 10(11):e0143112. PubMed ID: 26571389
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated double suicide gene selectively kills gastric cancer cells.
Luo XR; Li JS; Niu Y; Miao L
Asian Pac J Cancer Prev; 2012; 13(3):781-4. PubMed ID: 22631647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
